Sudden Cardiac Death in Systemic Sclerosis: Diagnostics to Assess Risk and Inform Management

Laura Ross1,2, Elizabeth Paratz2,3,4, Murray Baron5

  • 1Department of Rheumatology, St. Vincent's Hospital Melbourne, 41 Victoria Parade, Fitzroy, VIC 3065, Australia.

Insights

Systemic sclerosis (SSc) patients face a higher risk of sudden cardiac death (SCD) due to heart conditions like fibrosis and myocarditis. Further research is needed to understand SSc-specific SCD risk factors and prevention strategies.

Area of Science:

  • Cardiology
  • Rheumatology
  • Systemic Sclerosis Research

Background:

  • Cardiac disease is a primary cause of mortality in systemic sclerosis (SSc).
  • Sudden cardiac death (SCD) is presumed to be more frequent in SSc patients compared to the general population.
  • Myocardial fibrosis, myocarditis, and ischemic heart disease are common in SSc, potentially increasing SCD risk.

Purpose of the Study:

  • To review the mechanisms contributing to SCD in SSc.
  • To summarize current understanding of how these mechanisms lead to cardiac death.
  • To identify gaps in knowledge and propose future research directions for SSc-related SCD.

Main Methods:

  • Literature review of existing studies on cardiac disease in SSc.
  • Analysis of proposed pathophysiological mechanisms for SCD in SSc.
  • Synthesis of current evidence regarding SCD risk factors in SSc.

Main Results:

  • SSc is associated with significant cardiac involvement, including fibrosis and inflammation.
  • These cardiac conditions are hypothesized contributors to the elevated SCD risk in SSc.
  • There is a lack of comprehensive understanding regarding SSc-specific SCD risk factors and primary prevention.

Conclusions:

  • SCD is an understudied complication of systemic sclerosis.
  • Understanding SSc-specific risk factors is crucial for developing preventive strategies.
  • Future research should focus on the epidemiology of SCD in SSc and potential interventions.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
94
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
120
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
44
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
148
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
73
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
105